As discussed in Note 1, during the fourth quarter of the fiscal year ended January 31, 2026, the Company identified an immaterial error related to the timing of recognition of stock-based compensation expense in prior periods associated with certain awards granted in the fiscal years ended January 31, 2022 and 2023. To correct the immaterial error, the Company revised its previously issued unaudited Condensed Consolidated Financial Statements as of and for the three months ended April 30, 2025.

The following tables reflect the impacts of the revision to the previously filed financial statements for the three months ended April 30, 2025 (in thousands, except per share data):

Consolidated Statements of Stockholders’ Equity


	As of April 30, 2025
	As previously reported		Adjustments		As revised
Additional paid-in-capital	$	4,633,211	$	36,490	$	4,669,701
Accumulated deficit	$	(1,188,314)	$	(36,490)	$	(1,224,804)


	Three Months Ended April 30, 2025
	As previously reported		Adjustments		As revised
Subscription cost of revenue	$	242,374	$	(1,014)	$	241,360
Professional services cost of services	46,769		(254)		46,515
Total cost of revenue	289,143		(1,268)		287,875
Gross profit	814,291		1,268		815,559
Sales and marketing	439,617		(406)		439,211
Research and development	334,129		(3,203)		330,926
General and administrative	165,201		(1,066)		164,135
Total operating expenses	938,947		(4,675)		934,272
Loss from operations	(124,656)		5,943		(118,713)
Loss before provision for income taxes	(89,887)		5,943		(83,944)
Net loss	(110,993)		5,943		(105,050)
Net loss attributable to CrowdStrike	$	(110,207)	$	5,943	$	(104,264)
Net loss per share attributable to CrowdStrike common stockholders:
Basic	$	(0.44)	$	0.02	$	(0.42)
Diluted	$	(0.44)	$	0.02	$	(0.42)

There was no impact to the consolidated statements of cash flows from operating activities, investing activities, or financing activities for any period. The impact to the consolidated statements of comprehensive income (loss) is limited to the impact to net loss as detailed above.